Gene · 80331
Papers3,340
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 3,340
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unconventional Protein Secretion in Brain Tumors Biology: Enlightening the Mechanisms for Tumor Survival and Progression. | Front Cell Dev Biol | 2022 | 35784465 | PubTator, text mining | PubMed |
| Expanding the Malaria Antibody Toolkit: Development and Characterisation of Plasmodium falciparum RH5, CyRPA, and CSP Recombinant Human Monoclonal Antibodies. | Front Cell Infect Microbiol | 2022 | 35782147 | PubTator, text mining | PubMed |
| Expanded geographic distribution and host preference of Anopheles gibbinsi (Anopheles species 6) in northern Zambia. | Malar J | 2022 | 35780113 | PubTator, text mining | PubMed |
| In vitro models for human malaria: targeting the liver stage. | Trends Parasitol | 2022 | 35780012 | PubTator, text mining | PubMed |
| Mfsd8 Modulates Growth and the Early Stages of Multicellular Development in Dictyostelium discoideum. | Front Cell Dev Biol | 2022 | 35756993 | PubTator, text mining | PubMed |
| Labeling Strategies for Surface-Exposed Protein Visualization and Determination in Plasmodium falciparum Malaria. | Front Cell Infect Microbiol | 2022 | 35755836 | PubTator, text mining | PubMed |
| Human miRNAs to Identify Potential Regions of SARS-CoV-2. | ACS Omega | 2022 | 35755383 | PubTator, text mining | PubMed |
| An In Silico Analysis of Malaria Pre-Erythrocytic-Stage Antigens Interpreting Worldwide Genetic Data to Suggest Vaccine Candidate Variants and Epitopes. | Microorganisms | 2022 | 35744609 | PubTator, text mining | PubMed |
| Factors Associated With Human IgG Antibody Response to Anopheles albimanus Salivary Gland Extract, Artibonite Department, Haiti, 2017. | J Infect Dis | 2022 | 35711005 | PubTator, text mining | PubMed |
| Comparison of Antibody Responses and Parasite Clearance in Artemisinin Therapeutic Efficacy Studies in the Democratic Republic of Congo and Asia. | J Infect Dis | 2022 | 35703955 | PubTator, text mining | PubMed |
| Robust anti-SARS-CoV2 single domain antibodies cross neutralize multiple viruses. | iScience | 2022 | 35702569 | PubTator, text mining | PubMed |
| Growth rate determines prokaryote-provirus network modulated by temperature and host genetic traits. | Microbiome | 2022 | 35701838 | PubTator, text mining | PubMed |
| Identifying and Investigating Ambulatory Care Sequences Before Invasive Coronary Angiography. | Med Care | 2022 | 35700071 | PubTator, text mining | PubMed |
| Plasmodium falciparum 7G8 challenge provides conservative prediction of efficacy of PfNF54-based PfSPZ Vaccine in Africa. | Nat Commun | 2022 | 35697668 | PubTator, text mining | PubMed |
| Norovirus-VLPs expressing pre-erythrocytic malaria antigens induce functional immunity against sporozoite infection. | Vaccine | 2022 | 35697572 | PubTator, text mining | PubMed |
| Cyclic constrained immunoreactive peptides from crucial P. falciparum proteins: potential implications in malaria diagnostics. | Transl Res | 2022 | 35697275 | PubTator, text mining | PubMed |
| SARS-CoV-2: Molecular Structure, Pathogenesis, Potential Therapeutic Targets, and Immune Response of the Infected Subject. | Interdiscip Perspect Infect Dis | 2022 | 35694045 | PubTator, text mining | PubMed |
| The Centres for Disease Control light trap (CDC-LT) and the human decoy trap (HDT) compared to the human landing catch (HLC) for measuring Anopheles biting in rural Tanzania. | Malar J | 2022 | 35690745 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. | Toxicol Appl Pharmacol | 2022 | 35688186 | PubTator, text mining | PubMed |
| Application of Lignin-Containing Cellulose Nanofibers and Cottonseed Protein Isolate for Improved Performance of Paper. | Polymers (Basel) | 2022 | 35683825 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80331/papers?page=39